Tekla Capital Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$1.33M Buy
2022
Q3
Sell
2022
Q2
$967K Hold
2022
Q1
$2.9M Buy
2021
Q4
$3.46M Buy
2021
Q3
$1.53M Buy
2019
Q3
Sell
2019
Q2
$1.47M Sell
2019
Q1
$2.23M Sell
2018
Q4
$1.33M Sell
2018
Q3
$2.25M Hold
2018
Q2
$1.47M Hold
2018
Q1
$1.88M Buy
2017
Q4
$1.72M Buy
2017
Q3
$138K Buy